Projects per year
Personal profile
Research Statement
The Stratified Medicine Group focuses on the following areas:
1) Characterisation of a molecular group in solid cancers that represents an innate immune response to DNA damage through the STING pathway.
2) Development of a biomarker for anti-angiogenic agents
3) Development of a biomarker for MEKK pathway activation
4) Identification of a prognostic biomarker for early prostate cancer
5) Development of new cell lines for pre-clinical modelling of ovarian and prostate cancer.
Other
Linked in Profile:
https://www.linkedin.com/in/profkennedy/
Fingerprint
- 80 Similar Profiles
Network
Projects
-
R1005PMY: Artificial Intelligence Enables Clinical Decision Making in the Digital Healthcare Era
McArt, D., Kennedy, R. & Salto-Tellez, M.
12/02/2019 → …
Project: Research
-
R1523CNR: “S-CORT: Stratification in COloRectal cancer: from biology to Treatment prediction”.
Lawler, M., Johnston, P., Kennedy, R., Salto-Tellez, M. & Wilson, R.
29/04/2015 → …
Project: Research
-
R6416CNR: Phase 1B/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients
Van Schaeybroeck, S., Johnston, P., Kennedy, R., Lawler, M., Longley, D., Salto-Tellez, M. & Wilson, R.
01/08/2013 → …
Project: Research
-
R2116CNR: MOVEMBER CENTRE OF EXCELLENCE
O'Sullivan, J., Jain, S., Kennedy, R., McDade, S., Prise, K., Salto-Tellez, M. & Waugh, D.
21/05/2014 → 30/06/2019
Project: Research
Research Output
-
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Malla, S. B., Fisher, D. J., Domingo, E., Blake, A., Hassanieh, S., Redmond, K. L., Richman, S. D., Youdell, M., Walker, S. M., Logan, G. E., Chatzipli, A., Amirkhah, R., Humphries, M. P., Craig, S. G., McDermott, U., Seymour, M. T., Morton, D. G., Quirke, P., West, N. P., Salto-Tellez, M. & 12 others, , 01 Jan 2021, In : Clinical Cancer Research. 27, 1, p. 288-300Research output: Contribution to journal › Article › peer-review
-
ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation
Hanna, C., Dunne, V. L., Walker, S. M., Butterworth, K. T., McCabe, N., Waugh, D. J. J., Kennedy, R. D. & Prise, K. M., 30 Dec 2020, In : Cancers. 13, 1Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Identification of Src's role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches
McCabe, N. H., Stevenson, L., Scanlon, E., Keminer, O., Kennedy, R., Windshuegel, B., Blayney, J. & Turkington, R. C., 01 Aug 2020, In : Cancer Research. 80, 16 SupplementResearch output: Contribution to journal › Meeting abstract › peer-review
-
Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches
McCabe, N., Stevenson, L., Scanlon, E., Keminer, O., Kennedy, R., Windshuegel, B., Blayney, J. & Turkington, R., 22 Jun 2020.Research output: Contribution to conference › Abstract › peer-review
-
RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer
Khawaja, H., Campbell, A., Roberts, J. Z., Javadi, A., O’Reilly, P., McArt, D., Allen, W. L., Majkut, J., Rehm, M., Bardelli, A., Di Nicolantonio, F., Scott, C. J., Kennedy, R., Vitale, N., Harrison, T., Sansom, O. J., Longley, D. B., Evergren, E. & Van Schaeybroeck, S., 29 Oct 2020, In : Cell death and disease. 11, 10, 18 p., 930.Research output: Contribution to journal › Article › peer-review
Open AccessFile
Prizes
-
Queen’s University of Belfast Vice Chancellor Award for Innovation
Kennedy, Richard (Recipient), 2013
Prize: Prize (including medals and awards)
-
St Luke’s Medal for Cancer Research. Royal College of Medicine, Ireland
Kennedy, Richard (Recipient), 2015
Prize: Prize (including medals and awards)
Press / Media
-
Behind the Science. 30 minute TV programme on Cancer Research at QUB/Almac
13/12/2017
1 Media contribution
Press/Media: Public Engagement Activities
-
A visit to the Doctor in 2013. Public lecture.
10/10/2017
1 item of Media coverage
Press/Media: Public Engagement Activities
Impact
-
Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant) & Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact